124 related articles for article (PubMed ID: 11811532)
1. Fluvastatin depresses the enhanced lipid peroxidation in vitamin E-deficient hamsters.
Suzumura K; Ohashi N; Oka K; Yasuhara M; Narita H
Free Radic Res; 2001 Dec; 35(6):815-23. PubMed ID: 11811532
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro.
Suzumura K; Yasuhara M; Tanaka K; Suzuki T
Biochem Pharmacol; 1999 Mar; 57(6):697-703. PubMed ID: 10037456
[TBL] [Abstract][Full Text] [Related]
3. Antioxidative effect of fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on peroxidation of phospholipid liposomes.
Yamamoto A; Ichihara K; Hoshi K
J Pharm Pharmacol; 2001 Feb; 53(2):227-32. PubMed ID: 11273020
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of fluvastatin and its metabolites on hydrogen peroxide-induced oxidative destruction of hemin and low-density lipoprotein.
Suzumura K; Tanaka K; Yasuhara M; Narita H
Biol Pharm Bull; 2000 Jul; 23(7):873-8. PubMed ID: 10919369
[TBL] [Abstract][Full Text] [Related]
5. Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes.
Yamamoto A; Hoshi K; Ichihara K
Eur J Pharmacol; 1998 Nov; 361(1):143-9. PubMed ID: 9851551
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of fluvastatin, an HMG-CoA reductase inhibitor, on the formation of 8-oxo-2'-deoxyguanosine in the nuclear DNA of hamster pancreas after a single administration of N-nitrosobis(2-oxopropyl)amine.
Kaneko T; Tahara S; Takabayashi F
Biol Pharm Bull; 2003 Sep; 26(9):1245-8. PubMed ID: 12951466
[TBL] [Abstract][Full Text] [Related]
7. Fluvastatin reduces modification of low-density lipoprotein in hyperlipidemic rabbit loaded with oxidative stress.
Yamaguchi Y; Matsuno S; Kagota S; Haginaka J; Kunitomo M
Eur J Pharmacol; 2002 Feb; 436(1-2):97-105. PubMed ID: 11834252
[TBL] [Abstract][Full Text] [Related]
8. Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin.
Yamaguchi Y; Matsuno S; Kagota S; Haginaka J; Kunitomo M
Atherosclerosis; 2004 Feb; 172(2):259-65. PubMed ID: 15019535
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibitory effects of the optical isomers and metabolites of fluvastatin on copper ion-induced LDL oxidation.
Suzumura K; Odawara A; Yasuhara M; Tanaka K; Narita H; Suzuki T
Biol Pharm Bull; 1999 Sep; 22(9):971-4. PubMed ID: 10513623
[TBL] [Abstract][Full Text] [Related]
10. Fluvastatin, an HMG-CoA reductase inhibitor, protects LDL from oxidative modification in hypercholesterolemic rabbits.
Yasuhara M; Suzumura K; Tanaka K; Takahashi M; Aoki S; Odawara A; Narita H; Suzuki T
Biol Pharm Bull; 2000 May; 23(5):570-4. PubMed ID: 10823666
[TBL] [Abstract][Full Text] [Related]
11. [Antioxidative effects of fluvastatin, and its major metabolites].
Nakashima A; Ohtawa M; Masuda N; Morikawa H; Bando T
Yakugaku Zasshi; 1999 Jan; 119(1):93-9. PubMed ID: 9922713
[TBL] [Abstract][Full Text] [Related]
12. [Antioxidative effects of fluvastatin, and its major metabolites [II]].
Nakashima A; Ohtawa M; Masuda N; Morikawa H; Iwasaki K
Yakugaku Zasshi; 2001 Jan; 121(1):113-6. PubMed ID: 11201159
[TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction in streptozotocin-diabetic rats is not reversed by dietary probucol or simvastatin supplementation.
Palmer AM; Gopaul N; Dhir S; Thomas CR; Poston L; Tribe RM
Diabetologia; 1998 Feb; 41(2):157-64. PubMed ID: 9498648
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of fluvastatin on degradation of apolipoprotein B by a radical reaction in human plasma.
Aoki S; Ikeda K; Yamamura M; Kojo S
Biol Pharm Bull; 2001 Feb; 24(2):123-6. PubMed ID: 11217077
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits.
Mitani H; Bandoh T; Ishikawa J; Kimura M; Totsuka T; Hayashi S
Br J Pharmacol; 1996 Nov; 119(6):1269-75. PubMed ID: 8937733
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E.
De Caterina R; Cipollone F; Filardo FP; Zimarino M; Bernini W; Lazzerini G; Bucciarelli T; Falco A; Marchesani P; Muraro R; Mezzetti A; Ciabattoni G
Circulation; 2002 Nov; 106(20):2543-9. PubMed ID: 12427649
[TBL] [Abstract][Full Text] [Related]
17. Fluvastatin normalizes the decreased turnovers of glutathione and ascorbic acid in Watanabe heritable hyperlipidaemic rabbits.
Suzumura K; Kasahara E; Ohnishi Y; Chien KC; Inoue M
Clin Exp Pharmacol Physiol; 2000 Sep; 27(9):709-14. PubMed ID: 10972538
[TBL] [Abstract][Full Text] [Related]
18. Antioxidative effects of fluvastatin and its metabolites against DNA damage in streptozotocin-treated mice.
Imaeda A; Kaneko T; Aoki T; Kondo Y; Nakamura N; Nagase H; Yoshikawa T
Food Chem Toxicol; 2002 Oct; 40(10):1415-22. PubMed ID: 12387303
[TBL] [Abstract][Full Text] [Related]
19. Detection and localization of lipid peroxidation in selenium- and vitamin E-deficient rats using F2-isoprostanes.
Awad JA; Morrow JD; Hill KE; Roberts LJ; Burk RF
J Nutr; 1994 Jun; 124(6):810-6. PubMed ID: 8207538
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of amlodipine and fluvastatin on the deposition of advanced glycation end products in aortic wall of cholesterol and fructose-fed rabbits.
Akira K; Amano M; Okajima F; Hashimoto T; Oikawa S
Biol Pharm Bull; 2006 Jan; 29(1):75-81. PubMed ID: 16394514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
